RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR, COMPETITION AND PRACTICES
Impact
The implications of S3059 are significant for various stakeholders, including insurers, pharmacies, and consumers. By enforcing stricter regulations on PBMs, the bill aims to create a more equitable system where pharmacies can freely communicate pricing and service information to consumers. It also seeks to protect pharmacies from potentially exploitative practices by PBMs, such as prohibiting them from disclosing pertinent cost information. Furthermore, the introduction of an appeals process for pricing disputes aims to ensure that pharmacies can contest and resolve pricing discrepancies in a fair manner.
Summary
Bill S3059 is a legislative proposal aimed at enhancing transparency and accountability among pharmacy benefit managers (PBMs) within Rhode Island's healthcare system. It amends existing laws related to pharmacy operations and the management of prescription drug benefits. The bill establishes clear definitions and duties for PBMs, ensuring they operate with the same responsibilities as insurers when interacting with covered individuals. The legislation is framed as a response to growing concerns regarding the practices of PBMs that have impacts on both the cost and accessibility of prescription medications for patients.
Contention
Notably, the bill has sparked discussions concerning its potential impact on the competitive landscape of healthcare in Rhode Island. Supporters argue that increased transparency will lead to better healthcare outcomes and lower costs for consumers. However, opponents raise concerns that the bill could lead to unintended consequences, such as increased administrative burdens on PBMs and potential changes in how they negotiate with pharmacies. This debate reflects broader tensions in the healthcare sector regarding regulation and the role of intermediaries in the prescription drug supply chain.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.